170 related articles for article (PubMed ID: 19167030)
1. Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or older.
Froehner M; Koch R; Litz RJ; Wirth MP
Urology; 2009 Mar; 73(3):610-3; discussion 613-4. PubMed ID: 19167030
[TBL] [Abstract][Full Text] [Related]
2. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Walz J; Gallina A; Saad F; Montorsi F; Perrotte P; Shariat SF; Jeldres C; Graefen M; Bénard F; McCormack M; Valiquette L; Karakiewicz PI
J Clin Oncol; 2007 Aug; 25(24):3576-81. PubMed ID: 17704404
[TBL] [Abstract][Full Text] [Related]
3. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI
Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
Richstone L; Bianco FJ; Shah HH; Kattan MW; Eastham JA; Scardino PT; Scherr DS
BJU Int; 2008 Mar; 101(5):541-6. PubMed ID: 18257855
[TBL] [Abstract][Full Text] [Related]
6. A nomogram predicting metastatic progression after radical prostatectomy.
Porter CR; Suardi N; Kodama K; Capitanio U; Gibbons RP; Correa R; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
Int J Urol; 2008 Oct; 15(10):889-94. PubMed ID: 18662174
[TBL] [Abstract][Full Text] [Related]
7. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
[TBL] [Abstract][Full Text] [Related]
9. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Shariat SF; Walz J; Roehrborn CG; Zlotta AR; Perrotte P; Suardi N; Saad F; Karakiewicz PI
J Clin Oncol; 2008 Mar; 26(9):1526-31. PubMed ID: 18349404
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.
Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
Urology; 2006 Sep; 68(3):583-6. PubMed ID: 16979740
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
Walz J; Suardi N; Shariat SF; Jeldres C; Perrotte P; Graefen M; Widmer H; Arjane P; Valiquette L; Hutterer G; Saad F; Karakiewicz PI
BJU Int; 2008 Jul; 102(1):33-8. PubMed ID: 18384631
[TBL] [Abstract][Full Text] [Related]
12. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database.
Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ
BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946
[TBL] [Abstract][Full Text] [Related]
13. Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
J Urol; 2008 May; 179(5):1823-9; discussion 1829. PubMed ID: 18355873
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Haase M; Klenk U; Oehlschlaeger S; Baretton GB; Wirth MP
Scand J Urol Nephrol; 2005; 39(6):449-54. PubMed ID: 16303719
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
[TBL] [Abstract][Full Text] [Related]
17. Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds.
Yamamoto T; Ito K; Miyakubo M; Takechi H; Suzuki K; Akimoto T; Ishikawa H; Nakano T
Urology; 2008 Oct; 72(4):892-7. PubMed ID: 18372027
[TBL] [Abstract][Full Text] [Related]
18. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract][Full Text] [Related]
19. Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
Fleischmann A; Schobinger S; Schumacher M; Thalmann GN; Studer UE
Prostate; 2009 Mar; 69(4):352-62. PubMed ID: 19016478
[TBL] [Abstract][Full Text] [Related]
20. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Jeldres C; Suardi N; Walz J; Saad F; Hutterer GC; Bhojani N; Shariat SF; Perrotte P; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol; 2008 Jul; 54(1):107-16. PubMed ID: 17996358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
